The constitutive expression of PD-L1 may represent a previous endogenous anti-tumor immune response, which is slowed but failed to prevent tumor growth completely, and can be rejuvenated by PD-1/PD-L1 inhibitors [43]; (3). Here, CD274 is linked to neoplasm.